"There have been rapid changes in the standards of drug all over the world, stakeholders felt necessary to bring out new edition of the book as it would also help keep pace with the regulatory requirements," the Union minister said while releasing the book.
The standards given in the pharmacopoeia are authoritative, legally enforceable and intended to help in the inspection and licensing of manufacturing units and distribution of drugs and pharmaceuticals.
Azad noted that the latest edition has been considerably revised and improved by introducing advanced technology and experimental methods widely adopted in India and abroad.
It prescribes the standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines.
The scope of the Pharmacopoeia has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines and additional antiretroviral drugs and formulations, inclusive of commonly used fixed-dose combinations.
IP 2014 incorporates 2,548 monographs of drugs out of which 577 are new monographs consisting of APIs, excipients, dosage forms, antibiotic monographs, insulin products, and herbal products.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
